- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del completes acquisition of Gendex
Del Global Technologies of Valhalla, NY, reported last week thatit has finalized its purchase of the Gendex Medical division ofDentsply International. Del will operate its new property as Gendex-DelMedical Imaging, which will continue to be based in
Del Global Technologies of Valhalla, NY, reported last week that
it has finalized its purchase of the Gendex Medical division of
Dentsply International. Del will operate its new property as Gendex-Del
Medical Imaging, which will continue to be based in Gendex's home
town of Franklin Park, IL. Del said that it paid $7.5 million
in cash and a note for Gendex.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
